Meta-analysis of risk factors for cutaneous melanoma according to anatomical site and clinico-pathological variant

European Journal of Cancer

Volumn 45, Issue 17, 2009, Pages 3054-3063

  Caini, Saverio ^a   Gandini, Sara ^b   Sera, Francesco ^a   Raimondi, Sara ^b   Fargnoli, Maria Concetta ^c   Boniol, Mathieu ^d   Armstrong, Bruce K ^e  

^a ISPO   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

^d INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Body site; Epidemiology; Melanoma; Meta analysis; Naevus; Neoplasm by site; Neoplasms by histologic type; Phenotype; Sun exposure

Indexed keywords

ANATOMICAL VARIATION; ARTICLE; CANCER RISK; CLINICAL TRIAL; DISEASE ASSOCIATION; EYE COLOR; GENETIC VARIABILITY; HAIR COLOR; HISTOPATHOLOGY; HUMAN; LENTIGO; MELANOMA; META ANALYSIS; NEVUS; PRIORITY JOURNAL; SKIN COLOR; SUN EXPOSURE; SUNBURN; SYSTEMATIC REVIEW;

HAIR COLOR; HUMANS; MELANOMA; NEOPLASMS, RADIATION-INDUCED; RISK FACTORS; SKIN NEOPLASMS; SKIN PIGMENTATION; SUNLIGHT;

EID: 70350580944     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.05.009     Document Type: Article

References (67)

1. Lens M.B., and Dawes M. Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma. Br J Dermatol 150 (2004) 179-185
2. Karim-Kos H.E., de Vries E., Soerjomataram I., et al. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 44 10 (2008) 1345-1389
3. Gruber S.B., and Armstrong B.K. Cutaneous and ocular melanoma. In: Schottenfeld D., and Fraumeni J. (Eds). Cancer epidemiology and prevention (2006), Oxford University Press, New York 1282-1312
4. Green A. A theory of the site distribution of melanomas: Queensland, Australia. Cancer Cause Contr 3 6 (1992) 513-516
5. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41 (2005) 28-44
6. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41 (2005) 45-60
7. Gandini S., Sera F., Cattaruzza M.S., et al. Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41 (2005) 2040-2059
8. Greenland S. Quantitative methods in the review of epidemiologic literature. Epidemiol Rev 9 (1987) 1-30
9. Van Houwelingen H.C., Arends L.R., and Stijnen T. Advanced methods in meta-analysis: multivariate approach and meta-regression. Stat Med 21 (2002) 589-624
10. Greenland S., and Longnecker M.P. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135 (1992) 1301-1309
11. Higgins J.P., and Thompson S.G. Quantifying heterogeneity in a meta-analysis. Stat Med 21 (2002) 1539-1558
12. Begg C.B., and Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 50 (1994) 1088-1099
13. Egger M., Davey S.G., Schneider M., and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
14. Copas J., and Shi J.Q. Meta-analysis, funnel plots and sensitivity analysis. Biostatistics 1 3 (2000) 247-262
15. Copas J., and Shi J.Q. A sensitivity analysis for publication bias in systematic reviews. Stat Methods Med Res 10 4 (2001) 251-265
16. Storey J.D., and Tibshirani R. Statistical significance for genome wide studies. Proc Natl Acad Sci USA 100 (2003) 9440-9445
17. Whiteman D.C., Watt P., Purdie D.M., et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95 (2003) 806-812
18. Whiteman D.C., Stickley M., Watt P., et al. Anatomic site, sun exposure, and risk of cutaneous melanoma. J Clin Oncol 24 (2006) 3172-3177
19. Carli P., and Palli D. Re: Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst 95 (2003) 1801
20. Siskind V., Whiteman D.C., Aitken J.F., Martin N.G., and Green A.C. An analysis of risk factors for cutaneous melanoma by anatomical site (Australia). Cancer Cause Contr 16 (2005) 193-199
21. Rokuhara S., Saida T., Oguchi M., Matsumoto K., Murase S., and Oguchi S. Number of acquired melanocytic nevi in patients with melanoma and control subjects in Japan: nevus count is a significant risk factor for nonacral melanoma but not for acral melanoma. J Am Acad Dermatol 50 (2004) 695-700
22. Green A., McCredie M., MacKie R., et al. A case-control study of melanomas of the soles and palms (Australia and Scotland). Cancer Cause Contr 10 (1999) 21-25
23. Rolón P.A., Kramárová E., Rolón H.I., Khlat M., and Parkin D.M. Plantar melanoma: a case-control study in Paraguay. Cancer Cause Contr 8 (1997) 850-856
24. Holman C.D., and Armstrong B.K. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 72 (1984) 257-266
25. Holman C.D., and Armstrong B.K. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 73 (1984) 75-82
26. Holman C.D., Armstrong B.K., and Heenan P.J. Relationship of cutaneous malignant melanoma to individual sunlight-exposure habits. J Natl Cancer Inst 76 (1986) 403-414
27. Green A., Bain C., McLennan R., and Siskind V. Risk factors for cutaneous melanoma in Queensland. Recent Results Cancer Res 102 (1986) 76-97
28. Swerdlow A.J., English J., MacKie R.M., et al. Benign melanocytic naevi as a risk factor for malignant melanoma. BMJ 292 (1986) 1555-1559
29. Vågero D., Ringbäck G., and Kiviranta H. Melanoma and other tumors of the skin among office, other indoor and outdoor workers in Sweden 1961-1979. Br J Cancer 53 (1986) 507-512
30. Cristofolini M., Franceschi S., Tasin L., et al. Risk factors for cutaneous malignant melanoma in a northern Italian population. Int J Cancer 39 (1987) 150-154
31. Elwood J.M., Gallagher R.P., Worth A.J., Wood W.S., and Pearson J.C. Etiological differences between subtypes of cutaneous malignant melanoma: Western Canada Melanoma Study. J Natl Cancer Inst 78 (1987) 37-44
32. Østerlind A., Tucker M.A., Hou-Jensen K., et al. The Danish case-control study of cutaneous malignant melanoma. I. Importance of host factors. Int J Cancer 42 (1988) 200-206
33. Weinstock M.A., Colditz G.A., Willett W.C., et al. Moles and site-specific risk of nonfamilial cutaneous malignant melanoma in women. J Natl Cancer Inst 81 (1989) 948-952
34. Stierner U., Augustsson A., Rosdahl I., and Suurküla M. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study. Melanoma Res 1 (1992) 367-375
35. Weiss J., Bertz J., and Jung E.G. Malignant melanoma in southern Germany: different predictive value of risk factors for melanoma subtypes. Dermatologica 183 (1991) 109-113
36. Krüger S., Garbe G., Büttner P., et al. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects. J Am Acad Dermatol 26 (1992) 920-926
37. Herzfeld P.M., Fitzgerald E.F., Hwang S.A., and Stark A. A case-control study of malignant melanoma of the trunk among white males in upstate New York. Cancer Detect Prev 17 (1993) 601-608
38. Goodman K.J., Bible M.L., London S., and Mack T.M. Proportional melanoma incidence and occupation among white males in Los Angeles County (California, United States). Cancer Cause Contr 6 (1995) 451-459
39. Cress R.D., Holly E.A., Ahn D.K., LeBoit P.E., and Sagebiel R.W. Cutaneous melanoma in women: anatomic distribution in relation to sun exposure and phenotype. Cancer Epidemiol Biomarkers Prev 4 (1995) 831-836
40. Holly E.A., Aston D.A., Cress R.D., Ahn D.K., and Kristiansen J.J. Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 141 (1995) 923-933
41. Holly E.A., Aston D.A., Cress R.D., Ahn D.K., and Kristiansen J.J. Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 141 (1995) 934-942
42. Rieger E., Soyer H.P., Garbe C., et al. Overall and site-specific risk of malignant melanoma associated with nevus counts at different body sites: a multicenter case-control study of the German Central Malignant-Melanoma Registry. Int J Cancer 62 (1995) 393-397
43. Chen Y.T., Dubrow R., Holford T.R., et al. Malignant melanoma risk factors by anatomic site: a case-control study and polychotomous logistic regression analysis. Int J Cancer 67 (1996) 636-643
44. Grulich A.E., Bataille V., Swerdlow A.J., et al. Naevi and pigmentary characteristics as risk factors for melanoma in a high-risk population: a case-control study in New South Wales, Australia. Int J Cancer 67 (1996) 485-491
45. Ródenas J.M., Delgado-Rodríguez M., Farinas-Alvarez C., Herranz M.T., and Serrano S. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain. Am J Epidemiol 145 (1997) 1020-1029
46. Måsbäck A., Westerdahl J., Ingvar C., Olsson H., and Jonsson N. Clinical and histopathological characteristics in relation to aetiological risk factors in cutaneous melanoma: a population-based study. Melanoma Res 9 (1999) 189-197
47. Walter S.D., King W.D., and Marrett L.D. Association of cutaneous malignant melanoma with intermittent exposure to ultraviolet radiation: results of a case-control study in Ontario, Canada. Int J Epidemiol 28 (1999) 418-427
48. Langholz B., Richardson J., Rappaport E., et al. Skin characteristics and risk of superficial spreading and nodular melanoma (United States). Cancer Cause Contr 11 (2000) 741-750
49. Håkansson N., Floderus B., Gustavsson P., Feychting M., and Hallin N. Occupational sunlight exposure and cancer incidence among Swedish construction workers. Epidemiology 12 (2001) 552-557
50. Cho E., Rosner B.A., and Colditz G.A. Risk factors for melanoma by body site. Cancer Epidemiol Biomarkers Prev 14 (2005) 1241-1244
51. Naldi L., Altieri A., Imberti G.L., et al., Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy). Cancer Cause Contr 16 (2005) 893-899
52. Randi G., Naldi L., Gallus S., Di Landro A., La Vecchia C., and the Oncology Study Group of the Italian Group for Epidemiologic Research in Dermatology (GISED). Number of nevi at a specific anatomical site and its relation to cutaneous malignant melanoma. J Invest Dermatol 126 (2006) 2106-2110
53. Chang Y, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol 2009 [epub ahead of print].
54. Franceschi S., Levi F., Randimbison L., and La Vecchia C. Site distribution of different types of skin cancer: new aetiological clues. Int J Cancer 67 1 (1996) 24-28
55. Bulliard J.L., Cox B., and Elwood J.M. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer 72 2 (1997) 231-235
56. Lin J.Y., and Fisher D. Melanocyte biology and skin pigmentation. Nature 445 (2007) 843-850
57. Rees J.L. The genetics of sun sensitivity in humans. Am J Hum Genet 75 (2004) 739-751
58. Newell G.R., Sider J.G., Bergfelt L., and Kripke M. Incidence of cutaneous melanoma in the United States by histology with special reference to the face. Cancer Res 48 (1988) 5036-5042
59. Raimondi S., Sera F., Gandini S., et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122 (2008) 2753-2760
60. Landi M.T., Bauer J., Pfeiffer R.M., et al. MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313 5786 (2006) 521-522
61. Saldanha G., Potter L., Daforno P., and Pringle J.H. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies. Clin Cancer Res 12 15 (2006) 4499-4505
62. Debniak T., Scott R., Masojc T., et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 119 11 (2006) 2597-2602
63. Olsen C.M., Zens M.S., Stukel T.A., et al. Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer 124 4 (2009) 937-944
64. Stegmaier O.C. Natural regression of the melanocytic nevus. J Invest Dermatol 32 (1959) 413-421
65. Kumar R., Angelini S., Snellmann E., and Hemminki K. BRAF mutations are common somatic events in melanocytic naevi. J Invest Dermatol 122 2 (2004) 342-348
66. Maldonado J.L., Fridlyand J., Patel H., et al. Determinants of BRAF mutations in primary Melanomas. J Natl Cancer Inst 95 (2003) 1878-1880
67. Whiteman D.C., Parsons P.G., and Green A.C. P53 expression and risk factors for cutaneous melanoma: a case-control study. Int J Cancer 77 (1998) 843-848